Enfermedad mínima residual en cánceres colorrectales de alto riesgo resecados. Valor de las biopsias líquidas en el seguimiento y análisis de la heterogeneidad tumoral.
Datos básicos
- Protocolo:
- PI15/02180
- EUDRACT:
- NCT:
- Centro:
- Año de incio:
- 2016
- Año de finalización:
- 2019
Documentos
- No hay documentos
Participantes
Grupos y Plataformas de I+D+i
Financiadores - Promotores
Resultados del Ensayo Clínico
Addition of nivolumab to chemotherapy in patients with advanced gastric cancer: a relevant step ahead, but still many questions to answer.
Smyth, Elizabeth C, Cervantes, Andres
Editorial Material. 10.1136/esmoopen-2020-001107. 2020
Analytical Validation of Multiplex Biomarker Assay to Stratify Colorectal Cancer into Molecular Subtypes
Ragulan, C; (...); Sadanandam, A
Article. 10.1038/s41598-019-43492-0. 2019
Definition of the Rectum: An International, Expert-based Delphi Consensus.
D'Souza N; (...); Brown G
Article. 10.1097/SLA.0000000000003251. 2019
Detection of postoperative plasma circulating tumour DNA and lack of CDX2 expression as markers of recurrence in patients with localised colon cancer.
Tarazona, Noelia; (...); Cervantes, Andres
Article. 10.1136/esmoopen-2020-000847. 2020
EPDR1 up-regulation in human colorectal cancer is related to staging and favours cell proliferation and invasiveness.
Gimeno-Valiente, F; (...); Castillo, J
Article. 10.1038/s41598-020-60476-7. 2020
Epigenetic Mechanisms Are Involved in the Oncogenic Properties of ZNF518B in Colorectal Cancer.
Gimeno-Valiente, F; (...); Castillo, J
Article. 10.3390/cancers13061433. 2021
Improving tumor budding evaluation in colon cancer by extending the assessment area in colectomy specimen.
Martinez-Ciarpaglini, Carolina; (...); Cervantes, Andres
Article. 10.1111/his.13900. 2019
In the literature: December 2019
Gambardella, V; (...); Cervantes, A
Editorial Material. 10.1136/esmoopen-2019-000642. 2020
In the literature: February 2020
Roda, D; (...); Cervantes, A
Editorial Material. 10.1136/esmoopen-2020-000680. 2020
Low miR200c expression in tumor budding of invasive front predicts worse survival in patients with localized colon cancer and is related to PD-L1 overexpression
Martinez-Ciarpaglini, C; (...); Cervantes, A
Article. 10.1038/s41379-018-0124-5. 2019
Neoadjuvant Chemotherapy in Locally Advanced Rectal Cancer.
Papaccio, Federica; (...); Cervantes, Andres
Article. 10.3390/cancers12123611. 2020
Precision Medicine to Treat Advanced Gastroesophageal Adenocarcinoma: A Work in Progress.
Gambardella, Valentina; (...); Cervantes, Andres
Article. 10.3390/jcm9093049. 2020
Reply to the letter to the editor: adjuvant nivolumab for the management of the pathological residual disease in esophageal or junctional tumors: a word of caution by PK Garg, R. Kumar and P. Dixit
Smyth, E C; (...); Fleitas, T
Letter. 10.1016/j.annonc.2021.05.795. 2021
Targeted next-generation sequencing of circulating-tumor DNA for tracking minimal residual disease in localized colon cancer
Tarazona, N; (...); Cervantes, A
Article. 10.1093/annonc/mdz390. 2019
The role of tumor-associated macrophages in gastric cancer development and their potential as a therapeutic target.
Gambardella, V; (...); Fleitas, T
Article. 10.1016/j.ctrv.2020.102015. 2020
Towards precision oncology for anti-HER2 blockade in gastroesophageal adenocarcinoma.
Gambardella, V; (...); Cervantes, A
Review. 10.1093/annonc/mdz143. 2019
Understanding the clinical behavior of relapsed colon cancers with microsatellite instability relative to BRAF mutations.
Roda, D, Rosello, S, Cervantes, A
Editorial Material. 10.1093/annonc/mdz229. 2019
ZNF518B gene up-regulation promotes dissemination of tumour cells and is governed by epigenetic mechanisms in colorectal cancer.
Gimeno-Valiente F; (...); López-Rodas G
Article. 10.1038/s41598-019-45411-9. 2019